APA (7th ed.) Citation

Kim, H. R., Kang, H. N., Yun, M. R., Ju, K. Y., Choi, J. W., Jung, D. M., . . . Paik, S. (2020). Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck. British Journal of Cancer, 123(12), 1720. https://doi.org/10.1038/s41416-020-01074-2

Chicago Style (17th ed.) Citation

Kim, Hye Ryun, et al. "Mouse-human Co-clinical Trials Demonstrate Superior Anti-tumour Effects of Buparlisib (BKM120) and Cetuximab Combination in Squamous Cell Carcinoma of Head and Neck." British Journal of Cancer 123, no. 12 (2020): 1720. https://doi.org/10.1038/s41416-020-01074-2.

MLA (9th ed.) Citation

Kim, Hye Ryun, et al. "Mouse-human Co-clinical Trials Demonstrate Superior Anti-tumour Effects of Buparlisib (BKM120) and Cetuximab Combination in Squamous Cell Carcinoma of Head and Neck." British Journal of Cancer, vol. 123, no. 12, 2020, p. 1720, https://doi.org/10.1038/s41416-020-01074-2.